Cleared Abbreviated

K121084 - LOCI CARDIAC TROPONIN-I CONTROL (LOW)

K121084 is an FDA 510(k) clearance for LOCI CARDIAC TROPONIN-I CONTROL (LOW), manufactured by Siemens Healthcare Diagnostics, Inc.. The device is a Class 1 Chemistry device with product code JJX cleared through the Abbreviated 510(k) pathway after a 29-day FDA review.

K121084 · Siemens Healthcare Diagnostics, Inc. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2012
Decision
29d
Days
Class 1
Risk

K121084 is an FDA 510(k) clearance for the LOCI CARDIAC TROPONIN-I CONTROL (LOW), LCTNI CON L. Classified as Single (specified) Analyte Controls (assayed And Unassayed) (product code JJX), Class I - General Controls.

Submitted by Siemens Healthcare Diagnostics, Inc. (Newark, US). The FDA issued a Cleared decision on May 9, 2012 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1660 - the FDA in vitro diagnostics and chemistry framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Siemens Healthcare Diagnostics, Inc. devices

FDA 510(k) Submission Details - K121084

510(k) Number K121084 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 10, 2012
Decision Date May 09, 2012
Days to Decision 29 days
Submission Type Abbreviated
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
59d faster than avg
Panel avg: 88d · This submission: 29d
Pathway characteristics
Standards-based clearance path.

JJX Device Classification - Class 1, General Controls

Product Code JJX Single (specified) Analyte Controls (assayed And Unassayed)
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 862.1660
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - JJX Single (specified) Analyte Controls (assayed And Unassayed)

All 402
Devices cleared under the same product code (JJX) and FDA review panel - the closest regulatory comparables to K121084.
BETA HCG CONTROL LEVEL 1 BETA HCG CONTROL LEVEL 2 BETA HCG CONTROL LEVEL 3 BETA HCG CALIBRATION VERIFICATION CONTROLS LE
K121237 · Cliniqa Corporation · May 2012
COMPLETE D 25-OH VITAMIN D CONTROL
K113177 · Quantimetrix Corp. · May 2012
ELECSYS LH CALCHECK 5
K121279 · Roche Diagnostics · May 2012
ON CALL VIVID BLOOD GLUCOSE MONITORING SYSTEMS
K112653 · ACON Laboratories, Inc. · Apr 2012
IDS-ISYS IGFBP-3 CONTROL SET, IDS-ISYS HUMAN GROWTH HORMONE (HGH) CALIBRATION VERIFIERS, AND IDS-ISYS IGFBP-3 CAL...
K111938 · Immunodiagnostic Systems , Ltd. · Feb 2012
AUDIT MICROCV T-UPTAKE LINEARITY
K112143 · Aalto Scientific, Ltd. · Jan 2012